Grant
32.000 € / 2 yearsProf. Dr. Peter Ponsaerts - Prof. Dr. Annemie Van der Linden
The project
In vivo interleukin-13 mRNA gene therapy for modulation of neuroinflammatory lesions: a pre-clinical proof-of-concept study in the cuprizone mouse model of multiple sclerosis
University of Antwerpen